List view / Grid view
18 November 2015 | By Victoria White
Merck and Novapharm have announced a joint venture in Algeria to produce Merck’s diabetes and high blood pressure treatments for the Algerian market...
17 November 2015 | By Victoria White
The Pharmapack Europe Awards centralise the latest innovations in packaging and drug delivery, offering a unique view into tomorrow’s developments today...
17 November 2015 | By Victoria White
GBI Research says that the introduction of novel immune-checkpoint inhibitors, such as Opdivo and Keytruda, will drive the market...
17 November 2015 | By Victoria White
Darzalex (daratumumab) is the first human anti-CD38 monoclonal antibody (mAb) approved anywhere in the world...
17 November 2015 | By Victoria White
NICE has published final draft guidance not recommending the use of Kadcyla as a treatment for a type of advanced breast cancer because the price is too high...
17 November 2015 | By Victoria White
MED2002 is the Company’s novel gel for the treatment of erectile dysfunction...
17 November 2015 | By Victoria White
Once-daily Ultibro Breezhaler met its primary endpoint (non-inferiority) and also demonstrated superiority to twice-daily Seretide...
16 November 2015 | By Victoria White
The data show high rates of sustained virologic response at 12 weeks post-treatment in non-cirrhotic patients with chronic hepatitis C virus infection...
16 November 2015 | By CI Precision
CI Precision, global supplier of MES and weight sorting solutions, announces the release of version 6 of Ci-DMS, their manufacturing execution system (MES) which has gained established use in pharmaceuticals production...
16 November 2015 | By Victoria White
New research shows socio-cultural factors including time pressure, commuting time and where you live play significant roles in diabetes vulnerability...
16 November 2015 | By Victoria White
WHO's multi-country survey reveals people are confused about antibiotic resistance and do not understand how to prevent it from growing...
16 November 2015 | By Victoria White
The results come from a trial evaluating elbasvir/grazoprevir in patients with HCV infection who are receiving opioid agonist therapy...
16 November 2015 | By Victoria White
Results announced show that 95% of patients achieved a sustained virologic response at 12 weeks post-treatment...
16 November 2015 | By Victoria White
Adynovate has been shown to reduce the number of bleeding episodes during routine care...
13 November 2015 | By Victoria White
Tagrisso (AZD9291) is the only approved medicine indicated for patients with metastatic EGFR T790M mutation-positive non-small cell lung cancer...
